{"symbol": "SLDB", "companyName": "Solid Biosciences Inc.", "exchange": "Nasdaq Global Select", "industry": "Drug Manufacturers", "website": "http://www.solidbio.com", "description": "Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.", "CEO": "Ilan Ganot", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Drug Manufacturers - Specialty & Generic", "Drug Manufacturers"]}